Special Issue "Emerging Topics in (Endo)Cannabinoid Signalling"
Deadline for manuscript submissions: closed (31 October 2018)
Prof. Dr. Mauro Maccarrone
Department of Medicine, Campus Bio-Medico University of Rome, Rome, Italy;
European Center for Brain Research, Santa Lucia Foundation IRCCS, Rome, Italy
Website | E-Mail
Interests: endocannabinoid signaling; lipoxygenase pathway; Alzheimer's disease; Multiple Sclerosis; apoptosis; arachidonate cascade; resolvins
Extracts of cannabis plants (Cannabis sativa and Cannabis indica) have been used for centuries because of their recreational and therapeutic effects. However, it has only been around 50 years that we have known the identity of their most active principle [Δ9-tetrahydrocannabinol (THC)], and of the >110 compounds collectively termed “phytocannabinoids”. Shortly after the discovery of THC, it was recognized that endogenous ligands of the same targets activated by phytocannabinoids had to be present in our body, a concept that boosted active research leading to the discovery of N-arachidonoylethanolamine, 2-arachidonoylglycerol and other lipids as “endocannabinoids” (eCBs). Then, many more derivatives of ω-6 or ω-3 fatty acids were found to be biologically active eCBs, along with a multitude of compounds that were better considered “eCB-like” substances.
It seems now time to review the manifold actions of phytocannabinoids and eCBs in the central nervous system and at the periphery of our body, and to discuss hot topics and open questions of (endo)cannabinoid signalling that could represent an opportunity to discover new biomarkers and new therapeutic targets for disease treatment.Prof. Dr. Mauro Maccarrone
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug development
- metabolic enzymes
- signal transduction